Executive Summary
The two contracts analyzed total $239,740,078 in obligations, with one defense-related (NASA, civilian) and one civilian (NASA) contract, indicating a 1/2 defense-related split.
The dominant theme is NASA's continued investment in aerospace testing and space R&D, with Amentum Technology's $239.3M cost-plus-fixed-fee contract for facilities operations at Ames Research Center representing the bulk of the value, though its performance period ended in 2022, limiting forward-looking impact. Lockheed Martin's $424K sole-source R&D contract signals stable, low-risk demand but is immaterial to its revenue. The highest-conviction signal is the low pricing risk across both contracts due to cost-plus-fixed-fee structures, while the key risk is the potential lack of follow-on contracts for Amentum, given the contract's near-completion status.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior Contract Option Exercises digest from August 16, 2026.
Investment Signals (2)
- Amentum's Cost-Plus Contract Provides Stable, Low-Risk Revenue (MEDIUM)▲
Amentum's $239.3M NASA contract (cost-plus-fixed-fee) ensures predictable margins, with $120M already outlayed, indicating reliable cash flow. However, the contract's age and near-completion limit forward-looking upside.
- Lockheed Martin's Sole-Source R&D Contract Reinforces Entrenched Position (LOW)▲
Lockheed's $424K non-competitive award for space R&D (PISCES III) underscores its deep integration in NASA's R&D ecosystem, reducing competitive risk and signaling stable government demand.
Risk Flags (2)
- Concentration [MEDIUM RISK]▼
Amentum's contract represents 99.8% of the total obligation value, creating a concentration risk if NASA does not recompete or extend the ATOM-4 services. The contract's performance period ended in 2022, so future revenue is uncertain.
- Budget [LOW RISK]▼
Both contracts are from NASA, a civilian agency, and are subject to federal budget cycles. A continuing resolution or budget cuts could delay or reduce funding for facilities support and R&D, impacting Amentum and Lockheed.
Opportunities (2)
- ◆
Lockheed's sole-source award for PISCES III indicates potential for follow-on contracts or option exercises under the same program, given its entrenched position in NASA's space R&D.
- ◆
NASA's continued investment in aerospace testing and facilities support (Amentum) and basic space R&D (Lockheed) suggests stable or growing funding for space exploration, presenting opportunities for contractors in these niches.
Sector Themes (1)
- ◆
Both contracts are from NASA, highlighting the agency's consistent investment in operational support and foundational space research. Amentum's facilities support and Lockheed's R&D services indicate a stable demand for these capabilities.
Watch List (2)
- 👁
{"entity" => "Amentum Technology, Inc.", "reason" => "The $239.3M NASA contract is near completion; future revenue depends on recompete or follow-on awards.", "trigger" => "Recompete announcement for ATOM-4 services at NASA Ames Research Center"}
- 👁
{"entity" => "Lockheed Martin Corporation", "reason" => "The small sole-source R&D contract signals potential for larger awards under PISCES III or related programs.", "trigger" => "Option exercise or new R&D award under PISCES III"}
Get daily alerts with 2 investment signals, 2 risk alerts, 2 opportunities and full AI analysis of all 2 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Contract Option Exercises
🇺🇸 More from United States
View all →August 17, 2026
US Pre-Market SEC Filings Roundup — August 17, 2026
US Pre-Market SEC Filings Roundup
August 17, 2026
USA Corporate Events Calendar — August 17, 2026
USA Corporate Events Calendar
August 17, 2026
Dow Jones 30 Stocks SEC Filings — August 17, 2026
Dow Jones 30 Stocks SEC Filings
August 17, 2026
US Corporate Distress Financial Stress SEC Filings — August 17, 2026
US Corporate Distress Financial Stress SEC Filings